ID: ALA4532268

Max Phase: Preclinical

Molecular Formula: C23H33Cl2N5O2S

Molecular Weight: 514.52

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Cc1nn(C)c(C)c1N(C)S(=O)(=O)c1c(Cl)cc(CCCN2CCN3CCC[C@@H]3C2)cc1Cl

Standard InChI:  InChI=1S/C23H33Cl2N5O2S/c1-16-22(17(2)27(3)26-16)28(4)33(31,32)23-20(24)13-18(14-21(23)25)7-5-9-29-11-12-30-10-6-8-19(30)15-29/h13-14,19H,5-12,15H2,1-4H3/t19-/m1/s1

Standard InChI Key:  IMQPHOQRHBIWQQ-LJQANCHMSA-N

Associated Targets(Human)

Peptide N-myristoyltransferase 1 643 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Glycylpeptide N-tetradecanoyltransferase 109 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 514.52Molecular Weight (Monoisotopic): 513.1732AlogP: 3.88#Rotatable Bonds: 7
Polar Surface Area: 61.68Molecular Species: BASEHBA: 6HBD: 0
#RO5 Violations: 1HBA (Lipinski): 7HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 9.42CX LogP: 3.64CX LogD: 1.62
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.56Np Likeness Score: -1.57

References

1. Kersten C, Fleischer E, Kehrein J, Borek C, Jaenicke E, Sotriffer C, Brenk R..  (2020)  How To Design Selective Ligands for Highly Conserved Binding Sites: A Case Study Using N-Myristoyltransferases as a Model System.,  63  (5): [PMID:31423787] [10.1021/acs.jmedchem.9b00586]

Source